ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2830

Progression to and Type of Orthopaedic Surgery in Juvenile Vs. Adult-Onset Ankylosing Spondylitis

Deepak R. Jadon1, Gavin Shaddick2, Amelia Jobling3, Athimalaipet V Ramanan4 and Raj Sengupta1, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Department of Mathematics, University of Bath, Bath, United Kingdom, 3Department of Mathematical Sciences, University of Bath, Bath, United Kingdom, 4Paediatric Rheumatology, University of Bristol Hospital Trust, Bristol, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Juvenile Arthritis, orthopaedic, outcome measures and surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis IV - Clinical Aspects Axial Spondyloarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile-onset ankylosing spondylitis (JoAS) and adult-onset ankylosing spondylitis (AoAS) are subtypes of ankylosing spondylitis (AS) that may have different clinical outcome. We compared cohorts of JoAS and AoAS in terms of: (1) clinical characteristics; (2) clinical outcomes; (3) proceeding to and types of AS-related orthopaedic surgery.

 

Methods: A cohort study was conducted of all patients attending a dedicated AS clinic in a teaching hospital. Patients aged ≤16 years at symptom onset were categorised as JoAS, and ≥17 years as AoAS. Demographics, clinical parameters, composite indices ≤6 months of census, biological use, and history of AS-related orthopaedic surgery to the spine, root or peripheral joints were recorded. Univariate, multivariate logistic regression, and survival analyses were performed.

 

Results: 553 AS cases were studied: 162 JoAS; 391 AoAS. On univariate analyses (Table 1), no statistically significant differences were found between JoAS and AoAS in terms of HLA-B27 positivity, smoking, occurrence at any time of inflammatory bowel disease, psoriasis, enthesitis, or uveitis. JoAS cases had higher scores for two Bath AS Functional Index (BASFI) domains: bending forward from the waist (p=0.03); doing physically demanding activities (p=0.04).

On multivariate analyses adjusted for significant covariates (Table 2), compared to JoAS cases the AoAS cases were less likely to have: proceeded to surgery (odds ratio, OR 0.31; p<0.001); had a hip procedure (resurfacing or arthroplasty; OR 0.374; adjusted p=0.001); had a hip arthroplasty (OR 0.43; adjusted p=0.01). JoAS and AoAS were equally likely to have had hip resurfacing, bilateral hip arthroplasty, hip arthroplasty revision, hip arthroplasty re-revision, spinal orthopaedic surgery, and several (≥3) procedures.

Kaplan-Meier survival curves (log-rank test p=0.001) and Cox regression also demonstrated a significant difference in not having surgery between JoAS and AoAS (p=0.002) (Figure 1). A history of smoking was not associated with surgery. AS cases with older age at symptom onset were far less likely to have surgery than those with younger onset, in a non-linear manner.

 

Conclusion: JoAS are more likely than AoAS cases to proceed to AS-related orthopaedic surgery, especially hip resurfacing and arthroplasty.

 


Disclosure:

D. R. Jadon,
None;

G. Shaddick,
None;

A. Jobling,
None;

A. V. Ramanan,
None;

R. Sengupta,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/progression-to-and-type-of-orthopaedic-surgery-in-juvenile-vs-adult-onset-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology